355 related articles for article (PubMed ID: 31767163)
1. Impaired adult hippocampal neurogenesis in a mouse model of familial hypercholesterolemia: A role for the LDL receptor and cholesterol metabolism in adult neural precursor cells.
Engel DF; Grzyb AN; de Oliveira J; Pötzsch A; Walker TL; Brocardo PS; Kempermann G; de Bem AF
Mol Metab; 2019 Dec; 30():1-15. PubMed ID: 31767163
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
4. Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia.
Jones C; Hammer RE; Li WP; Cohen JC; Hobbs HH; Herz J
J Biol Chem; 2003 Aug; 278(31):29024-30. PubMed ID: 12746448
[TBL] [Abstract][Full Text] [Related]
5. LDL Receptor Deficiency Does not Alter Brain Amyloid-β Levels but Causes an Exacerbation of Apoptosis.
de Oliveira J; Engel DF; de Paula GC; Melo HM; Lopes SC; Ribeiro CT; Delanogare E; Moreira JCF; Gelain DP; Prediger RD; Gabilan NH; Moreira ELG; Ferreira ST; de Bem AF
J Alzheimers Dis; 2020; 73(2):585-596. PubMed ID: 31815695
[TBL] [Abstract][Full Text] [Related]
6. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
[TBL] [Abstract][Full Text] [Related]
7. Exosome-based
Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
[TBL] [Abstract][Full Text] [Related]
8. High Cholesterol Diet Exacerbates Blood-Brain Barrier Disruption in LDLr-/- Mice: Impact on Cognitive Function.
de Oliveira J; Engel DF; de Paula GC; Dos Santos DB; Lopes JB; Farina M; Moreira ELG; de Bem AF
J Alzheimers Dis; 2020; 78(1):97-115. PubMed ID: 32925052
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
10. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.
Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH
J Clin Invest; 2007 Jan; 117(1):165-74. PubMed ID: 17200716
[TBL] [Abstract][Full Text] [Related]
11. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
[TBL] [Abstract][Full Text] [Related]
12. Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo.
Harada-Shiba M; Takagi A; Marutsuka K; Moriguchi S; Yagyu H; Ishibashi S; Asada Y; Yokoyama S
Circ Res; 2004 Oct; 95(9):945-52. PubMed ID: 15472122
[TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
15. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
[TBL] [Abstract][Full Text] [Related]
16. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
[TBL] [Abstract][Full Text] [Related]
17. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia.
Santos PC; Morgan AC; Jannes CE; Turolla L; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2014 Mar; 233(1):206-10. PubMed ID: 24529145
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice.
Ettcheto M; Petrov D; Pedrós I; de Lemos L; Pallàs M; Alegret M; Laguna JC; Folch J; Camins A
Exp Gerontol; 2015 May; 65():69-78. PubMed ID: 25797218
[TBL] [Abstract][Full Text] [Related]
20. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
